Allan Coukell is Pew’s senior director for health programs. He oversees initiatives related to drug and medical device innovation and safety, medical conflicts-of-interest, the pharmaceutical supply chain, pharmacy compounding, antibiotic resistance, prescription drug abuse, FDA, specialty drugs, food safety, school nutrition, as well as other efforts related to health costs and care delivery.
Prior to joining Pew, he practiced as a clinical pharmacist in oncology at the London Health Sciences Center and Ontario Regional Cancer Center, served as a senior medical writer and editor with the medical journal publisher Adis International, and covered health and science as a reporter and producer for WBUR (NPR) in Boston and Radio New Zealand. He is Vice Chair of the Medical Device Innovation Consortium and a board member of the Reagan Udall Foundation for the FDA. He served previously as consumer representative on the FDA’s Cardiovascular and Renal Drugs Advisory Committee.
On April 15, The Pew Charitable Trusts sent a letter to Senators Roy Blunt (R-MO) and Patty Murray (D-WA), and to Representatives Tom Cole (R-OK) and Rosa DeLauro (D-CT), urging them to include funding for the prevention and treatment of opioid use disorders in their committees’ fiscal year 2017 Labor, Health and Human Services, Education, and Related Agencies appropriations bills. Read More
The Pew Charitable Trusts is pleased to offer comments to the Substance Abuse and Mental HealthServices Administration (SAMHSA) on the proposed rule addressing changes to the Confidentiality ofAlcohol and Drug Abuse Records. Read More
President Barack Obama’s plan to increase access to effective substance abuse treatment was met with a standing ovation in Atlanta yesterday at the National Rx Drug Abuse & Heroin Summit, where clinicians, public health officials, and law enforcement personnel gathered to discuss solutions to the nation’s epidemic of opioid abuse and overdose deaths. Read More